Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Búsqueda
Corea y enfermedad de Huntington Chorea & Huntington’s disease 224 artículos Viendo del 1 al 40 de 224 artículos
Pub MED

Evolving Motivations: Patients' and Caregivers' Perceptions About Seeking Myotonic Dystrophy (DM1) and Huntington's Disease Care.NUEVO

LaDonna KA, Watling CJ, Ray SL, Piechowicz C, Venance SL.
Qual Health Res. 2017 Sep;27(11):1727-1737. doi: 10.1177/1049732317711901. Epub 2017 Jun 19.
Pub MED

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.NUEVO

Moss DJH, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S; TRACK-HD investigators.; REGISTRY investigators., Holmans P, Jones L, Tabrizi SJ.
Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20.
Pub MED

Identifying modifiers of Huntington's disease progression.NUEVO

Saft C.
Lancet Neurol. 2017 Sep;16(9):679-680. doi: 10.1016/S1474-4422(17)30179-5. Epub 2017 Jun 20. No abstract available.
Pub MED

Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease.NUEVO

Sebastianutto I, Cenci MA, Fieblinger T.
Neurobiol Dis. 2017 Sep;105:117-131. doi: 10.1016/j.nbd.2017.05.011. Epub 2017 Jun 1.
Pub MED

Huntington's disease with severe neck infection.NUEVO

Hino S, Kaneko T, Horie N, Shimoyama T.
Gerodontology. 2017 Sep;34(3):401-403. doi: 10.1111/ger.12277. Epub 2017 May 19.
Pub MED

Oxytocin selectively modulates brain processing of disgust in Huntington's disease gene carriers.NUEVO

Labuschagne I, Poudel G, Kordsachia C, Wu Q, Thomson H, Georgiou-Karistianis N, Stout JC.
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Sep 22. pii: S0278-5846(17)30572-9. doi: 10.1016/j.pnpbp.2017.09.023. [Epub ahead of print]
Pub MED

1993-2014: two decades of predictive testing for Huntington's disease at the Medical Genetics Unit of the University of Genoa.NUEVO

Mandich P, Lamp M, Gotta F, Gulli R, Iacometti A, Marchese R, Bellone E, Abbruzzese G, Ferrandes G.
Mol Genet Genomic Med. 2017 Jun 17;5(5):473-480. doi: 10.1002/mgg3.238. eCollection 2017 Sep.
Pub MED

Characterization of subventricular zone-derived progenitor cells from mild and late symptomatic YAC128 mouse model of Huntington's disease.NUEVO

Silva AC, Ferreira IL, Hayden MR, Ferreiro E, Cristina Rego A.
Biochim Biophys Acta. 2017 Sep 19. pii: S0925-4439(17)30324-1. doi: 10.1016/j.bbadis.2017.09.009. [Epub ahead of print]
Pub MED

Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease.NUEVO

Bellosta Diago E, Pérez Pérez J, Santos Lasaosa S, Viloria Alebesque A, Martínez Horta S, Kulisevsky J, López Del Val J.
Parkinsonism Relat Disord. 2017 Sep 15. pii: S1353-8020(17)30342-5. doi: 10.1016/j.parkreldis.2017.09.013. [Epub ahead of print]
Pub MED

Changes in striatal activity and functional connectivity in a mouse model of Huntington's disease.NUEVO

Cabanas M, Bassil F, Mons N, Garret M, Cho YH.
PLoS One. 2017 Sep 21;12(9):e0184580. doi: 10.1371/journal.pone.0184580. eCollection 2017.
Pub MED

Model-Based Magnetization Transfer Imaging Markers to Characterize Patients and Asymptomatic Gene Carriers in Huntington's Disease.NUEVO

Wiest R, Burgunder JM, Kiefer C.
Front Neurol. 2017 Sep 6;8:465. doi: 10.3389/fneur.2017.00465. eCollection 2017.
Pub MED

Chorea in acute carbon monoxide intoxication.NUEVO

Cação G, Freitas J, Neves S, Camacho O, Damásio J.
Neurol Sci. 2017 Sep 19. doi: 10.1007/s10072-017-3124-1. [Epub ahead of print] No abstract available.
Pub MED

An Automated Home-Cage System to Assess Learning and Performance of a Skilled Motor Task in a Mouse Model of Huntington's Disease.NUEVO

Woodard CL, Bolaños F, Boyd JD, Silasi G, Murphy TH, Raymond LA.
eNeuro. 2017 Sep 18;4(5). pii: ENEURO.0141-17.2017. doi: 10.1523/ENEURO.0141-17.2017. eCollection 2017 Sep-Oct.
Pub MED

Globular glial tauopathy presenting as non-fluent/agrammatic variant primary progressive aphasia with chorea.NUEVO

Kim EJ, Lee MJ, Lee JH, Lee YM, Shin JH, Shin MJ, Choi KU, Jung NY, Pak K, Hwang C, Ahn JW, Sung S, Spina S, Grinberg LT, Seeley WW, Huh GY.
Parkinsonism Relat Disord. 2017 Sep 6. pii: S1353-8020(17)30331-0. doi: 10.1016/j.parkreldis.2017.09.006. [Epub ahead of print] No abstract available.
Pub MED

Therapies targeting DNA and RNA in Huntington's disease.NUEVO

Wild EJ, Tabrizi SJ.
Lancet Neurol. 2017 Oct;16(10):837-847. doi: 10.1016/S1474-4422(17)30280-6. Epub 2017 Sep 12. Review.
Pub MED

Utilization of hospice services in a population of patients with Huntington's Disease.NUEVO

Johnson MO, Frank S, Mendlik M, Casarett D.
J Pain Symptom Manage. 2017 Sep 12. pii: S0885-3924(17)30468-2. doi: 10.1016/j.jpainsymman.2017.09.004. [Epub ahead of print]
Pub MED

Design optimization for clinical trials in early-stage manifest Huntington's disease.NUEVO

Frost C, Mulick A, Scahill RI, Owen G, Aylward E, Leavitt BR, Durr A, Roos RAC, Borowsky B, Stout JC, Reilmann R, Langbehn DR, Tabrizi SJ, Sampaio C; TRACK-HD Investigators..
Mov Disord. 2017 Sep 14. doi: 10.1002/mds.27122. [Epub ahead of print]
Pub MED

Case report of hyperglycemic nonketotic chorea with rapid radiological resolution.NUEVO

Herath HMMTB, Pahalagamage SP, Senanayake S.
BMC Med Imaging. 2017 Sep 12;17(1):54. doi: 10.1186/s12880-017-0228-2.
Pub MED

NMR Spectroscopy-based Metabolomics of Drosophila Model of Huntington's Disease Suggests Altered Cell Energetics.NUEVO

Singh V, Sharma RK, Athilingam T, Sinha P, Sinha N, Thakur AK.
J Proteome Res. 2017 Sep 26. doi: 10.1021/acs.jproteome.7b00491. [Epub ahead of print]
Pub MED

Chorea Minor Associated with Anti-Neurochondrin Autoantibodies.NUEVO

Rommel FR, Miske R, Stöcker W, Arneth B, Neubauer BA, Hahn A.
Neuropediatrics. 2017 Sep 29. doi: 10.1055/s-0037-1606371. [Epub ahead of print] No abstract available.
Pub MED

The Neuropsychology of Huntington's Disease.NUEVO

Snowden JS.
Arch Clin Neuropsychol. 2017 Sep 18:1-12. doi: 10.1093/arclin/acx086. [Epub ahead of print]
Pub MED

Effectiveness of levodopa treatment for diabetic chorea with reduced striatal accumulation in dopamine transporter SPECT: a case report.NUEVO

Yokoi K, Kazuta T, Torii R, Endo T, Araki A, Terao S.
Rinsho Shinkeigaku. 2017 Sep 28. doi: 10.5692/clinicalneurol.cn-001041. [Epub ahead of print]
Pub MED

Alterations in mRNA 3' UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington's Disease Brains.NUEVO

Romo L, Ashar-Patel A, Pfister E, Aronin N.
Cell Rep. 2017 Sep 26;20(13):3057-3070. doi: 10.1016/j.celrep.2017.09.009.
Pub MED

A PDE10A de novo mutation causes childhood-onset chorea with diurnal fluctuations.NUEVO

Esposito S, Carecchio M, Tonduti D, Saletti V, Panteghini C, Chiapparini L, Zorzi G, Pantaleoni C, Garavaglia B, Krainc D, Lubbe SJ, Nardocci N, Mencacci NE.
Mov Disord. 2017 Sep 26. doi: 10.1002/mds.27175. [Epub ahead of print] No abstract available.
Pub MED

Corticostriatal signatures of schadenfreude: evidence from Huntington's disease.

Baez S, Pino M, Berrío M, Santamaría-García H, Sedeño L, García AM, Fittipaldi S, Ibáñez A.
J Neurol Neurosurg Psychiatry. 2017 Aug 1. pii: jnnp-2017-316055. doi: 10.1136/jnnp-2017-316055. [Epub ahead of print]
Pub MED

Potential biomarker breakthrough for Huntington's disease.

Ross CA, Bang J.
Lancet Neurol. 2017 Aug;16(8):573-574. doi: 10.1016/S1474-4422(17)30195-3. Epub 2017 Jun 7. No abstract available.
Pub MED

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.

Byrne LM, Rodrigues FB, Blennow K, Durr A, Leavitt BR, Roos RAC, Scahill RI, Tabrizi SJ, Zetterberg H, Langbehn D, Wild EJ.
Lancet Neurol. 2017 Aug;16(8):601-609. doi: 10.1016/S1474-4422(17)30124-2. Epub 2017 Jun 7.
Pub MED

Safety and Exploratory Efficacy at 36 Months in Open-HART, an Open-Label Extension Study of Pridopidine in Huntington's Disease.

McGarry A, Kieburtz K, Abler V, Grachev ID, Gandhi S, Auinger P, Papapetropoulos S, Hayden M.
J Huntingtons Dis. 2017 Aug 12. doi: 10.3233/JHD-170241. [Epub ahead of print]
Pub MED

Selective Sparing of Striatal Interneurons after Poly (ADP-Ribose) Polymerase 1 Inhibition in the R6/2 Mouse Model of Huntington's Disease.

Paldino E, Cardinale A, D'Angelo V, Sauve I, Giampà C, Fusco FR.
Front Neuroanat. 2017 Aug 2;11:61. doi: 10.3389/fnana.2017.00061. eCollection 2017.
Pub MED

Beneficial effects of glatiramer acetate in Huntington's disease mouse models: evidence for BDNF-elevating and immunomodulatory mechanisms.

Corey-Bloom J, Aikin AM, Gutierrez A, Salam J, Howell T, Thomas EA.
Brain Res. 2017 Aug 17. pii: S0006-8993(17)30349-9. doi: 10.1016/j.brainres.2017.08.013. [Epub ahead of print]
Pub MED

Ribosomal transcription is regulated by PGC-1alpha and disturbed in Huntington's disease.

Jesse S, Bayer H, Alupei MC, Zügel M, Mulaw M, Tuorto F, Malmsheimer S, Singh K, Steinacker J, Schumann U, Ludolph AC, Scharffetter-Kochanek K, Witting A, Weydt P, Iben S.
Sci Rep. 2017 Aug 17;7(1):8513. doi: 10.1038/s41598-017-09148-7.
Pub MED

Huntington's disease: a clinical review.

McColgan P, Tabrizi SJ.
Eur J Neurol. 2017 Aug 17. doi: 10.1111/ene.13413. [Epub ahead of print]
Pub MED

Epidemiological Study of Huntington's Disease in the Province of Ferrara, Italy.

Carrassi E, Pugliatti M, Govoni V, Sensi M, Casetta I, Granieri E.
Neuroepidemiology. 2017 Aug 12;49(1-2):18-23. doi: 10.1159/000479697. [Epub ahead of print]
Pub MED

Lithium Sensitivity of Store Operated Ca2+ Entry and Survival of Fibroblasts Isolated from Chorea-Acanthocytosis Patients.

Pelzl L, Elsir B, Sahu I, Bissinger R, Singh Y, Sukkar B, Honisch S, Schoels L, Jemaà M, Lang E, Storch A, Hermann A, Stournaras C, Lang F.
Cell Physiol Biochem. 2017 Aug 11;42(5):2066-2077. doi: 10.1159/000479901. [Epub ahead of print]
Pub MED

Induced neural stem cells as a means of treatment in Huntington's disease.

Choi KA, Hong S.
Expert Opin Biol Ther. 2017 Aug 9:1-11. doi: 10.1080/14712598.2017.1365133. [Epub ahead of print]
Pub MED

Tics as an initial manifestation of juvenile Huntington's disease: case report and literature review.

Cui SS, Ren RJ, Wang Y, Wang G, Chen SD.
BMC Neurol. 2017 Aug 8;17(1):152. doi: 10.1186/s12883-017-0923-1.
Pub MED

Genetics of disease severity in multiple sclerosis, Alzheimer's disease, and Huntington's disease: rejuvenating genome-wide association studies.

Hrastelj J, Robertson N.
J Neurol. 2017 Aug 7. doi: 10.1007/s00415-017-8584-y. [Epub ahead of print] No abstract available.
Pub MED

Altered behavioral responses to gamma-aminobutyric acid pharmacological agents in a mouse model of Huntington's disease.

Hsu YT, Chang YG, Chang CP, Siew JJ, Chen HM, Tsai CH, Chern Y.
Mov Disord. 2017 Aug 7. doi: 10.1002/mds.27107. [Epub ahead of print]
Pub MED

A qualitative examination of physiotherapist led community-based yoga for individuals with Huntington's disease.

Ulanowski EA, Danzl M, Schwartz V, Reed C.
Complement Ther Clin Pract. 2017 Aug;28:146-151. doi: 10.1016/j.ctcp.2017.06.002. Epub 2017 Jun 8.
Pub MED

AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington's disease.

Miniarikova J, Zimmer V, Martier R, Brouwers CC, Pythoud C, Richetin K, Rey M, Lubelski J, Evers MM, van Deventer SJ, Petry H, Déglon N, Konstantinova P.
Gene Ther. 2017 Aug 3. doi: 10.1038/gt.2017.71. [Epub ahead of print]
Viendo del 1 al 40 de 224 artículos
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy
Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.